Dr. Elizabeth A Lawson, MD
Claim this profileMassachusetts General Hospital, Neuroendocrine Unit
Studies Obesity
Studies Oxytocin
3 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Elizabeth A Lawson, MD is currently running
Oxytocin
for Adolescent Obesity
This is a randomized, double blind, placebo-controlled study of the effects of intranasal oxytocin in youths with obesity, ages 12-18 years old. Subjects will be randomized to receive intranasal oxytocin or placebo (1 spray per nostril, 4 times per day) for 12 weeks. Study visits include screening to determine eligibility, 2-part main study visits at baseline, week 8, and week 12, and safety check-in visits at weeks 1, and 4; phone calls at weeks 2, 6, and 10, with a safety follow-up visit 6 weeks after the last dose of study drug. Study procedures include appetite, behavioral, metabolic, and endocrine assessments.
Recruiting0 awards Phase 23 criteria
Intranasal Oxytocin
for Central Diabetes Insipidus
This is a randomized, double-blind, placebo-controlled crossover pilot study of single-dose intranasal oxytocin (6 IU and 24 IU) vs. placebo in adult men and women (aged 18 years and above) with arginine-vasopressin deficiency to evaluate the effect of oxytocin on anxiety, depression, and socioemotional functioning (Part A), with an optional randomized, double-blind, placebo-controlled 2-week repeated dose substudy of intranasal oxytocin 6 IU or placebo (Part B). Following a screening visit to determine eligibility, participants will return for three main study visits in Part A. During the main study visits, study participants will receive either oxytocin or placebo, followed by assessments of emotional behavior. In Part A, thirty participants will be equally randomized to one of six possible groups: 1. 6 IU oxytocin - 24 IU oxytocin - placebo 2. 6 IU oxytocin - placebo - 24 IU oxytocin 3. 24 IU oxytocin - 6 IU oxytocin - placebo 4. 24 IU oxytocin - placebo - 6 IU oxytocin 5. placebo - 6 IU oxytocin - 24 IU oxytocin 6. placebo - 24 IU oxytocin - 6 IU oxytocin Following completion of the Part A crossover portion of the study, in Part B participants may also choose to continue participation in an optional, randomized, double-blind, placebo-controlled substudy of intranasal oxytocin 6 IU or placebo three times a day for two weeks, followed by assessments of emotional behavior.
Recruiting0 awards Phase 13 criteria
More about Elizabeth A Lawson, MD
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Elizabeth A Lawson, MD has experience with
- Oxytocin Nasal Spray
- Placebo
- Intranasal Oxytocin Spray
- Intranasal Oxytocin Spray
- Intranasal Placebo Spray
Breakdown of trials Elizabeth A Lawson, MD has run
Oxytocin
Childhood Obesity
Autism Spectrum Disorder
Osteoporosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elizabeth A Lawson, MD specialize in?
Elizabeth A Lawson, MD focuses on Obesity and Oxytocin. In particular, much of their work with Obesity has involved treating patients, or patients who are undergoing treatment.
Is Elizabeth A Lawson, MD currently recruiting for clinical trials?
Yes, Elizabeth A Lawson, MD is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Elizabeth A Lawson, MD has studied deeply?
Yes, Elizabeth A Lawson, MD has studied treatments such as Oxytocin nasal spray, Placebo, Intranasal oxytocin spray.
What is the best way to schedule an appointment with Elizabeth A Lawson, MD?
Apply for one of the trials that Elizabeth A Lawson, MD is conducting.
What is the office address of Elizabeth A Lawson, MD?
The office of Elizabeth A Lawson, MD is located at: Massachusetts General Hospital, Neuroendocrine Unit, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital, Neuroendocrine Unit.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.